 |
 |

Self-management of Age-related Macular Degeneration at the 6-Month Follow-up
A Randomized Controlled Trial
Barbara L. Brody, MPH;
Anne-Catherine Roch-Levecq, PhD;
Ronald G. Thomas, PhD;
Robert M. Kaplan, PhD;
Stuart I. Brown, MD
Arch Ophthalmol. 2005;123:46-53.
Objective To assess the effectiveness at the 6-month follow-up of an age-related macular degeneration (AMD) self-management program consisting of health education and enhancement of problem-solving skills in improving quality of life as shown by measures of mood and function.
Methods Six-month follow-up data were analyzed from 214 of 252 older adult volunteers (mean age, 80.8 years) with advanced AMD who had been randomly assigned to a 12-hour self-management program (n = 82), a series of 12 hours of tape-recorded health lectures (n = 66), or a waiting list (n = 66). The primary outcome measure was emotional distress (Profile of Mood States). Secondary outcome measures included function (National Eye Institute Visual Function Questionnaire), self-confidence to handle AMD-specific challenges in daily life (AMD Self-efficacy Questionnaire), and depression status on the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
Results At the 6-month follow-up, participants in the self-management program reported significantly less emotional distress (P=.008), better function (P=.05), and increased self-efficacy (P=.006) compared with control subjects. The latter effects were more pronounced in the depressed than in the nondepressed subjects. Finally, the incidence of clinical depression at the 6-month follow-up was significantly lower in the self-management group (P=.05) than in the control group.
Conclusion The sustained positive effects at the 6-month follow-up provide support for the effectiveness of the AMD self-management program in reducing distress and disability, improving self-efficacy, and preventing depression in poorly sighted elderly patients with AMD.
Author Affiliations: Divisions of Biostatistics (Dr Thomas) and Health Care Sciences (Dr Kaplan), Departments of Ophthalmology (Ms Brody and Drs Roch-Levecq and Brown), Family and Preventive Medicine (Ms Brody and Drs Thomas and Kaplan), and Neurosciences (Dr Thomas), University of California, San Diego, La Jolla.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Depression and the vision-related quality of life in patients with retinitis pigmentosa
Hahm et al.
Br. J. Ophthalmol. 2008;92:650-654.
ABSTRACT
| FULL TEXT
Anxiety and Depression Prevalence Rates in Age-Related Macular Degeneration
Augustin et al.
IOVS 2007;48:1498-1503.
ABSTRACT
| FULL TEXT
Impact of age related macular degeneration on quality of life
Hassell et al.
Br. J. Ophthalmol. 2006;90:593-596.
ABSTRACT
| FULL TEXT
|